| Name | hyodeoxycholic acid |
|---|---|
| Synonyms |
HYODEOXYCHOLIC ACID (RG)
Apigenine Impurity 2 3ALPHA, 6ALPHA-DIHYDROXY-5BETA-CHOLANIC ACID Iodeoxycholic acid 3à,6à-dihydroxy-5á-cholan-24-oic acid 3a,6a-Dihydroxy-5beta-cholan-24-oic acid 5β-CHOLANIC ACID-3α, 6α-DIOL 4-[(2R,5R,7R,8S,14R,15R)-5,8-dihydroxy-2,15-diMethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]htadecan-14-yl]pentanoic acid ALPHA-HYODESOXYCHOLIC ACID 3α, 6α-Dihydroxy-5beta-cholan-24-oic acid 3α,6α-Dihydroxy-5β-cholan-24-oic acid Hyodeoxycholic acid(HDCA) 4-(3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 3α,6α-dihydroxy-5β-cholanic acid 3ALPHA,6ALPHA-DIHYDROXY-5BETA-CHOLAN-24-OIC ACID 5β-Cholan-24-Oic Acid-3α,6α-Diol (R)-4-((3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid EINECS 201-483-2 alpha-HYDROXYDEOXYCHOLIC ACID HYODEOXYCHOLANIC ACID HYDROCHOLIC ACID 3-ALPHA,6-ALPHA-DIHYDROXY-5-ALPHA-CHOLAN-24-OIC ACID 3.alpha.,6.alpha.-Dihydroxycholanic acid Hyodeoxycholic acid, >= MFCD00003681 Hyodeoxycholicacid 3a,6a-Dihydroxy-5b-Cholan-24-Oic Acid Cholan-24-oic acid, 3,6-dihydroxy-, (3α,5β,6α) Cholan-24-oic acid, 3,6-dihydroxy-,(3α,5β,6α) 7-deoxyhyocholicacid HyodeoxychoL (3R,5R,6S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-5-methylhex-5-en-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol HYODEOXYCHOLIC ACID FREE ACID Nsc60672 Pig deoxybile acid 3α,6α-Dihydroxy-5β-cholanoic acid 6-alpha-hydroxylithocholicacid 5.beta.-Cholan-24-oic acid, 3.alpha.,6.alpha.-dihydroxy Hyodeoxycholic 5BETA-CHOLAN-24 OIC ACID-3ALPHA,6ALPHA-DIOL 3alpha,6alpha-Dihydroxy-5beta-cholanoic acid 4-{5,9-dihydroxy-2,15-diMethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]htadecan-14-yl}pentanoic acid (4R)-4-((3R,5R,6S,10R,13R,17R)-3,6-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phena 3,6-dihydroxy-,(3alpha,5beta,6alpha)-cholan-24-oicaci α-Hyodeoxycholic Acid HYODEOXYCHOLIC ACID hyodeoxycholic acid GMP 5-BETA-CHOLANIC ACID-3-ALPHA, 6-ALPHA-DIOL alpha-hyodeoxycholicacid Hyodeoxycholic acid,3α,6α-Dihydroxy-5β-cholan-24-oic acid (4R)-4-((3R,5R,6S,10R,13R,17R)-3,6-dihydroxy-10,13-diMethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 3-alpha,6-alpha-dihydroxy-5-beta-cholan-24-oicaci Hyodesoxycholic Acid (HDCA) HYODESOXYCHOLIC ACID Cholan-24-oic acid, 3,6-dihydroxy-, (3.alpha.,5.beta.,6.alpha.) Hyodeoxycholic acid //BP Deoxycholic Acid Impurity 4(α-Hyodeoxycholic Acid) 3α, 6α-dihydroxycholanic acid HDCA |
| Description | Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 µM in CHO cells. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | Hyodeoxycholic acid is a secondary hydrophilic bile acid formed in the small intestine by the gut flora, and acts as an agonist of TGR5, with an EC50 of 31.6 µM in CHO cells[1]. Hyodeoxycholic acid (50, 100 μM) increases the expression of genes (Abca1, Abcg1, and Apoe) involved in cholesterol efflux in RAW 264.7 cells[2]. |
| In Vivo | Hyodeoxycholic acid (HDCA; 1.25% (wt/wt)) obviously decreases fat mass and increases lean mass but does not raise the serum levels of any organ toxicity markers in LDLRKO mice. Hyodeoxycholic acid inhibits atherosclerotic lesion formation in LDLRKO at multiple sites, improves plasma lipoprotein profiles, decreases plasma glucose level and intestinal cholesterol absorption efficiency and increases daily cholesterol excretion through fecal output. Hyodeoxycholic acid also improves HDL function as measured by a cholesterol efflux assay[2]. |
| Animal Admin | Mice[2] For atherosclerosis studies, 8-wk-old female LDLRKO mice are fed a Western diet (21% fat, 0.15% cholesterol; TD.88137) for 8 wk. One group of mice (baseline group) is euthanized at this time point for lesion measurement in the aortic root region and in the innominate artery. Atherosclerotic lesion in the whole aorta is not examined in the baseline group. The remaining mice are then divided into 2 groups and fed the following diets for another 15 wk before euthanasia: group 1, chow diet (5% fat, AIN-76A Rodent Diet); and group 2, chow diet + 1.25% (wt/wt) Hyodeoxycholic acid. For other studies, 8-wk-old female LDLRKO mice are fed a chow diet or chow diet + 1.25% Hyodeoxycholic acid for 3 wk before phenotype measurements. Food consumption and body weight are recorded weekly. Animals are measured for total body fat mass and lean mass by magnetic resonance imaging (MRI) using Bruker Minispec with software from Eco Medical Systems[2]. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 547.1±25.0 °C at 760 mmHg |
| Melting Point | 200-201 °C(lit.) |
| Molecular Formula | C24H40O4 |
| Molecular Weight | 392.572 |
| Flash Point | 298.8±19.7 °C |
| Exact Mass | 392.292664 |
| PSA | 77.76000 |
| LogP | 5.00 |
| Vapour Pressure | 0.0±3.3 mmHg at 25°C |
| Index of Refraction | 1.543 |
| Storage condition | Refrigerator |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . R40:Limited evidence of a carcinogenic effect. |
| Safety Phrases | S26-S36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | FZ2050000 |